Search hospitals > Pennsylvania > Philadelphia

Abramson Cancer Center of the University of Pennsylvania

Claim this profile
Philadelphia, Pennsylvania 19104
Global Leader in Breast Cancer
Global Leader in Parotid Gland Cancer
Conducts research for Cancer
Conducts research for Lung Cancer
Conducts research for Lymphoma
947 reported clinical trials
74 medical researchers
Photo of Abramson Cancer Center of the University of Pennsylvania in PhiladelphiaPhoto of Abramson Cancer Center of the University of Pennsylvania in Philadelphia

Summary

Abramson Cancer Center of the University of Pennsylvania is a medical facility located in Philadelphia, Pennsylvania. This center is recognized for care of Breast Cancer, Parotid Gland Cancer, Cancer, Lung Cancer, Lymphoma and other specialties. Abramson Cancer Center of the University of Pennsylvania is involved with conducting 947 clinical trials across 639 conditions. There are 74 research doctors associated with this hospital, such as Angela DeMichele, MD, Arati Desai, MD, Amy Clark, and Mark O'Hara, MD.

Area of expertise

1Breast Cancer
Global Leader
Abramson Cancer Center of the University of Pennsylvania has run 121 trials for Breast Cancer. Some of their research focus areas include:
Stage IV
ER positive
Stage III
2Parotid Gland Cancer
Global Leader
Abramson Cancer Center of the University of Pennsylvania has run 114 trials for Parotid Gland Cancer. Some of their research focus areas include:
Stage IV
Stage III
Stage I

Top PIs

Clinical Trials running at Abramson Cancer Center of the University of Pennsylvania

Breast Cancer
Esophageal Adenocarcinoma
Esophageal Carcinoma
Cancer
Lung Cancer
Gastroesophageal Junction Adenocarcinoma
Lymphoma
Parotid Gland Cancer
Breast cancer
Bladder Cancer
Image of trial facility.

Sacituzumab Govitecan

for Triple-Negative Breast Cancer

This trial is testing a drug called sacituzumab govitecan-hziy, which targets and kills cancer cells. It focuses on patients with advanced triple-negative breast cancer who have limited treatment options. The drug works by attaching to cancer cells and releasing a substance that kills them. Sacituzumab govitecan-hziy is an FDA-approved treatment for metastatic triple-negative breast cancer, especially for patients who have already tried other treatments.
Recruiting4 awards Phase 3
Image of trial facility.

Chemotherapy + Hormone Therapy

for Breast Cancer

This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Image of trial facility.

Radiation Therapy

for Brain Metastasis

This phase III trial compares the effectiveness of fractionated stereotactic radiosurgery (FSRS) to usual care stereotactic radiosurgery (SRS) in treating patients with cancer that has spread from where it first started to the brain. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. FSRS delivers a high dose of radiation to the tumor over 3 treatments. SRS is a type of external radiation therapy that uses special equipment to position the patient and precisely give a single large dose of radiation to a tumor. FSRS may be more effective compared to SRS in treating patients with cancer that has spread to the brain.
Recruiting2 awards Phase 312 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Abramson Cancer Center of the University of Pennsylvania?
Where is Abramson Cancer Center of the University of Pennsylvania located?
Who should I call to ask about financial aid or insurance network?
What insurance does Abramson Cancer Center of the University of Pennsylvania accept?
What awards or recognition has Abramson Cancer Center of the University of Pennsylvania received?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security